Department of Pathology, First Affiliated Hospital of Weifang Medical University, Weifang People's Hospital, Weifang 261041, China.
Department of Science, Qingdao Geneis Institute of Big Data Mining and Precision Medicine, Qingdao, China.
Biomed Res Int. 2021 Feb 10;2021:6612776. doi: 10.1155/2021/6612776. eCollection 2021.
Lymphangioleiomyomatosis (LAM) is a rare low-grade metastatic tumor; however, LAM patients were always found in young age with difficulty for diagnosis. Our study is aimed at observing the clinical characteristics of patients with lymphangiomatosis, including the clinical manifestations, imaging findings, histopathological features, and immunophenotype.
We did a systematic review on LAM/PLAM cases, especially on male cases, and collected the clinical features and molecular mechanisms of PLAM based on previous findings.
Diagnosis criteria were summarized by combining CT scans, MRI, immunohistochemistry results, and gene sequencing results for effectively distinguishing between PLAM and similar diseases. Moreover, our study illustrated the molecular mechanism of PLAM as well as the signaling pathway involved in the disease initials. In addition, a male case was reported with differential diagnosis on the clinical manifestations, microscopic features, immunophenotypes, and genotypes.
Our review will definitely improve the understanding of diagnosis and treatment in PLAM cases.
淋巴管平滑肌瘤病(LAM)是一种罕见的低度转移性肿瘤;然而,LAM 患者通常在年轻时被发现,诊断困难。本研究旨在观察淋巴管平滑肌瘤病患者的临床特征,包括临床表现、影像学表现、组织病理学特征和免疫表型。
我们对 LAM/PLAM 病例进行了系统综述,特别是男性病例,并根据以往的发现收集了 PLAM 的临床特征和分子机制。
通过结合 CT 扫描、MRI、免疫组织化学结果和基因测序结果,总结了诊断标准,可有效区分 PLAM 和相似疾病。此外,本研究还阐述了 PLAM 的分子机制以及疾病初始涉及的信号通路。此外,报告了一例男性病例,其临床表现、镜下特征、免疫表型和基因型存在差异。
本综述必将提高对 PLAM 病例的诊断和治疗的认识。